NCT01607112View on ClinicalTrials.gov

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above

PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

July 10, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix/Influsplit SSW 2012-2013

1 dose administered intramuscularly (or deeply subcutaneously) in the deltoid region of the non-dominant arm

Trial Locations (4)

01097

GSK Investigational Site, Dresden

01099

GSK Investigational Site, Dresden

01129

GSK Investigational Site, Dresden

01309

GSK Investigational Site, Dresden

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01607112 - A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above | Biotech Hunter | Biotech Hunter